Cargando…
RELB: A novel prognostic marker for glioblastoma as identified by population-based analysis
Glioblastoma multiforme (GBM) is the most common and malignant type of glioma, with a poor prognosis for patients. The survival time of patients varies greatly due to the complexity of the human genome, which harbors diverse oncogenic drivers. In order to identify the specific driving factors, 325 g...
Autores principales: | Zeng, Fan, Wang, Kuanyu, Huang, Ruoyu, Liu, Yanwei, Zhang, Ying, Hu, Huimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540354/ https://www.ncbi.nlm.nih.gov/pubmed/31289510 http://dx.doi.org/10.3892/ol.2019.10296 |
Ejemplares similares
-
RGS16 promotes glioma progression and serves as a prognostic factor
por: Huang, Ruoyu, et al.
Publicado: (2020) -
CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in high-grade glioma
por: Wang, Kuanyu, et al.
Publicado: (2018) -
ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2(Q607R)
por: Zhang, Ying, et al.
Publicado: (2018) -
RelB and Neuroinflammation
por: Mockenhaupt, Karli, et al.
Publicado: (2021) -
Receptor tyrosine kinase expression in high-grade gliomas before and after chemoradiotherapy
por: Wang, Kuanyu, et al.
Publicado: (2019)